Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8783280 | Middle East Fertility Society Journal | 2017 | 6 Pages |
Abstract
Objective: The purpose of the present study was to evaluate the immunocontraceptive effects of the monoclonal antibody bZP3 on ovarian morphology and ovarian expression of Bcl-2, FSH receptor and AMH. Study design: Thirty-six female mice of Balb/c strain were divided into six groups: three groups injected with 50 μl of phosphate buffer saline and observed at days 5, 10 and 20, and three groups injected with 50 μl of monoclonal antibody ZP3 and observed at days 5, 10 and 20. Ovarian morphology was histopathologically analyzed. Ovarian expression of FSH receptor, AMH and Bcl-2 was subjected to immunohistochemical analysis. Results: There was no significant difference in the number of follicles and granulosa cells' diameter and number among different treatment groups (p > 0.05). Pre-antral and antral follicular expression of Bcl-2, FSH receptor and AMH did not differ significantly among treatment groups (p > 0.05). Conclusion: In conclusion, immunocontraceptive administration of the monoclonal antibody bZP3 did not induce changes in morphology, cellular survival, protein expression, expression of FSH receptor and AMH levels.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Sutrisno Sutrisno, Heti Ira Ayue, Milatun Khanifah, Ummu Zakiah, Sri Poeranto, Sanarto Santoso,